glp-1 agonist and heart failure Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes The Cardiovascular Biology of Glucagon-like

In the STEP 1 trial, semaglutide 2.4 mg (Wegovy) demonstrated average weight loss of approximately 15% of body weight over 68 weeks

And then you found out what GLP-1s actually cost without insurance ($900 $1,500 per month at retail pharmacies) and the number stopped you cold

Drug safety-related labeling changes (SrLC)

This streamlines dispensation and reimbursement of incretin mimetics prescribed during follow-up specialist and primary care visits at affiliated hospital-run clinics

Shigeto M, Cha CY, Rorsman P, Kaku K

Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus